Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.

@article{en2011ElevatedPA,
  title={Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.},
  author={Nihat Şen and Mehmet Fatih Ozlu and Emin Ozgur Akgul and Selçuk Kanat and Tuncer Çayci and Osman Turak and H. Ruhi Yaman and Erdogan Sokmen and Firat Ozcan and Orhan Maden and Ahmet Duran Demir and Adrian Constantin Covic and Mehmet Kanbay},
  journal={Atherosclerosis},
  year={2011},
  volume={219 1},
  pages={304-10}
}
OBJECTIVES We aimed to investigate the effects of admission asymmetric dimethylarginine (ADMA) levels on myocardial perfusion and prognosis in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). BACKGROUND ADMA, an endogenous inhibitor of endothelial nitric oxide synthase, was found to be elevated in plasma of patients with cardiovascular risk factors. METHODS 168 consecutive patients undergoing primary PCI for STEMI <12 h… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Asymmetric dimethylargi - nine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease

  • C Zoccali, S Bode-Böger, F Mallamaci
  • Arterioscler Thromb Vasc Biol
  • 2006

Asymmetric dimethylarginine and the riskof cardiovascular events anddeath inpatientswithcoronaryarterydisease : results from the AtheroGene Study

  • TK Krempl, SydowK Maas R
  • Circ Res
  • 2005

Similar Papers

Loading similar papers…